Pentagon Adds Psilocin to the Drug Testing Panel Starting October 1, 2025, the Department of Defense will begin military psilocin testing as part of its expanded Drug Demand Reduction Program. A recent memo confirms that service members’ samples will now be screened for psilocin, the metabolite of psilocybin mushrooms. Officials argue that psychedelic use poses risks...
As we reflect on our incredible weekend in Denver, we feel uplifted, inspired, and energized for the future. Exhibiting with both of our organizations—our research and manufacturing hub, The Bunk Police, and our nonprofit organization, Transparency—felt like a rewarding, comprehensive showcase of everything we’ve achieved to get to this moment. This mission is often...
With overdose as the leading cause of death for adults ages 18–45 in the U.S., the search for the solution to the drug crisis is becoming more pressing every day. As a harm reduction organization implementing cutting edge technology at every opportunity, we have harnessed the power of AI to create a novel harm reduction...
With “psychedelics” headlining articles left and right, and “harm reduction” turning into a household name, this year is bound to be a revolutionary time for advancements and policy changes in the drug space. Even the U.S. government is jumping on board, with a budget of $509.4 million specifically dedicated to harm reduction efforts—up 26%...
